Levetiracetam
Product Images NDC 54868-6269

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 54868-6269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 mg (6075)

Levetiracetam 500 mg tablets packaging label from Physicians Total Care, Inc. The label indicates a quantity of 30 tablets per bottle with the NDC 54868-6075-1. It includes caution information about prescription dispensing and usage instructions advising to keep the medication out of reach of children, and storage guidelines to keep the bottle tightly closed and store at room temperature.*

FDA Label Image

1000 mg (6076)

Packaging label for Levetiracetam 1000 mg tablets distributed by Physicians Total Care, Inc. The label includes lot number 0000 and an expiration date of 01/60. Manufactured by Torrent Pharmaceuticals Ltd., India. The label features an NDC barcode and NDC number 54868-6076-0.*

FDA Label Image

750 mg (6269)

Levetiracetam 750 mg tablet bottle label by Physicians Total Care, Inc. The label states the package contains 60 tablets and includes a caution that federal law prohibits dispensing without a prescription. Additional label information includes directions for use, warnings regarding child-resistant packaging, storage instructions, dry tamper-evidence, and a lot number and expiration date area.*

FDA Label Image

Str (Levetiracetamplr Figure 01)

Chemical structure of levetiracetam, showing a 2-oxopyrrolidine ring attached to an ethyl group and an amide functional group.*

FDA Label Image

Fig 1 (Levetiracetamplr Figure 02)

Bar chart showing the percentage of patients responding to placebo and two daily doses of Levetiracetam (1000 mg/day and 3000 mg/day). The y-axis represents the percentage of patients, with placebo at 7.4%, Levetiracetam 1000 mg/day at 37.1%, and Levetiracetam 3000 mg/day at 39.6%. Sample sizes are shown below each group.*

FDA Label Image

Fig 2 (Levetiracetamplr Figure 03)

Bar chart showing the percentage of patients for Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day groups. The y-axis represents the percentage of patients, with Placebo at 6.3%, Levetiracetam 1000 mg/day at 20.8%, and Levetiracetam 2000 mg/day at 35.2%. The x-axis labels include the treatment groups and sample sizes.*

FDA Label Image

Fig 3 (Levetiracetamplr Figure 04)

Bar chart comparing the percentage of patients between a placebo group (104 patients) and a Levetiracetam group (180 patients) receiving 3000 mg/day. The Levetiracetam group shows a higher percentage of patients at 39.4% compared to 14.4% for the placebo group.*

FDA Label Image

Fig 4 (Levetiracetamplr Figure 05)

A bar graph comparing the percentage of patients between placebo and Levetiracetam groups. The y-axis represents the percentage of patients, showing approximately 19.6% for placebo (N=97) and 44.6% for Levetiracetam (N=101).*

FDA Label Image

Fig 5 (Levetiracetamplr Figure 06)

A bar chart comparing the percentage of patients between a placebo group (N=51) and a Levetiracetam group (N=58). The chart shows 19.6% for the placebo group and 43.1% for the Levetiracetam group, indicating a higher percentage for Levetiracetam.*

FDA Label Image

Fig 6 (Levetiracetamplr Figure 07)

A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The x-axis lists Placebo (N=84) and Levetiracetam (N=79), and the y-axis shows the percentage of patients from 0% to 100%. The Placebo bar reaches about 45.2%, while the Levetiracetam bar reaches about 72.2% with an asterisk indicating statistical significance or noteworthy difference.*

FDA Label Image

Logo (Levetiracetamplr Figure 08)

FDA Label Image

Logo (Levetiracetamplr Figure 09)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.